We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, EC Outline Challenges to Personalized Medicine
FDA, EC Outline Challenges to Personalized Medicine
November 1, 2013
The FDA and the European Commission have issued almost simultaneous reports outlining their efforts to regulate drug and device development in the context of personalized medicine.